BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 16330871)

  • 1. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population.
    Laniado-Laborin R; Rendón A; Bauerle O
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):818-23. PubMed ID: 21575305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
    Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
    Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old.
    Geijer RM; Sachs AP; Hoes AW; Salomé PL; Lammers JW; Verheij TJ
    Fam Pract; 2005 Oct; 22(5):485-9. PubMed ID: 15964866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Productive cough is an independent risk factor for the development of COPD in former smokers.
    Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
    Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of obstructive lung disease in a rural setting in the Philippines.
    Idolor LF; DE Guia TS; Francisco NA; Roa CC; Ayuyao FG; Tady CZ; Tan DT; Banal-Yang S; Balanag VM; Reyes MT; Dantes RB
    Respirology; 2011 Oct; 16(7):1111-8. PubMed ID: 21801277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
    Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
    Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
    Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
    Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study.
    Zachariades AG; Zachariadou T; Adamide T; Anagnostopoulou U; Georgiou A; Gourgoulianis KI
    COPD; 2012 Jun; 9(3):259-67. PubMed ID: 22432899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.